Covid-19 roundup: Plant-based shot proves safe, 71% ef­fi­ca­cious in PhI­II; Bourla ex­pects an­tivi­ral to launch this month

Que­bec-based Med­ica­go and its ad­ju­vant part­ner Glax­o­SmithK­line said Tues­day that their plant-based Covid-19 vac­cine can­di­date proved to be 71% ef­fi­ca­cious against all vari­ants of SARS …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER